Zimmer Biomet Other Stockholder Equity Over Time

ZBH Stock  USD 100.52  0.61  0.61%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Zimmer Biomet Performance and Zimmer Biomet Correlation.
  
The Zimmer Biomet's current Other Stockholder Equity is estimated to increase to about 2.8 B.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Dividend Share
0.96
Earnings Share
4.43
Revenue Per Share
37.807
Quarterly Revenue Growth
0.043
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Other Stockholder Equity Analysis

Compare Zimmer Biomet Holdings and related stocks such as Orthofix Medical, SurModics, and Pulmonx Corp Other Stockholder Equity Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Capex To DepreciationPb Ratio
RoicInventory Turnover
Net Income Per SharePayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioIncome Quality
RoeEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowEarnings Yield
Intangibles To Total AssetsNet Debt To E B I T D A
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Ev To SalesFree Cash Flow Per Share
Days Of Inventory On HandAverage Inventory
Capex To RevenueCash Per Share
Days Payables OutstandingNet Current Asset Value
Tangible Asset ValueTangible Book Value Per Share
Graham NumberShareholders Equity Per Share
Capex Per ShareGraham Net Net
Average ReceivablesInterest Debt Per Share
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Days Of Payables OutstandingCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales Outstanding
2010201120122013201420152016201720182019202020212022202320242025
OFIX25 M212.1 M243.6 M215.4 M232.8 M231.9 M204.1 M220.4 M243.2 M271 M292.3 M314 M335 M746.5 M858.4 M901.3 M
SRDX32.6 M19.3 MM2.2 M4.6 M6.8 M5.4 M7.3 M10.7 M15.4 M21.6 M28.8 M36.7 M118.2 M106.4 M111.7 M
LUNG21.1 M21.1 M21.1 M21.1 M21.1 M21.1 M21.1 M21.1 M21.1 M(183.6 M)467.1 M482.9 M502.7 M526.8 M605.8 M333.1 M
CVRX(221.3 M)(221.3 M)(221.3 M)(221.3 M)(221.3 M)(221.3 M)(221.3 M)(221.3 M)(221.3 M)(221.3 M)58.6 M540.7 M545.4 M553.3 M636.3 M324.9 M
EW833 M(105.3 M)(260.9 M)(584.8 M)(678.5 M)(890.2 M)(1.3 B)914.8 M369 M344.6 M(466 M)(716.5 M)(2.2 B)(2.8 B)(2.5 B)(2.4 B)
MDT700 K2.9 B3.2 B3.5 B(1.2 B)32.2 B29.6 B28.1 B26.5 B26.2 B26.3 B24.6 B24.6 B23.1 B26.6 B27.9 B
ABT733.6 M(9.8 T)(5.6 B)(6.8 B)(8.7 B)(10.6 B)(10.8 B)(10.2 B)(10 B)(10.1 B)(10 B)(11.8 B)(15.2 B)(16 B)(14.4 B)(15.1 B)
BSX33.1 M15.9 B15.3 B15 B15 B15.1 B15.3 B15.4 B15.6 B15.8 B17.5 B17.7 B18 B18.4 B21.2 B22.2 B
SYK4.5 MB1.1 B1.2 B1.3 B1.3 B1.4 B1.5 B1.6 B1.6 B1.7 B1.9 BB2.2 B2.4 B2.5 B
ITGR63.4 M305.8 M320.2 M343.7 M364.8 M617.4 M632.1 M665.1 M683 M692.2 M700.8 M713.1 M731.4 M727.4 M836.6 M447.3 M

Zimmer Biomet Holdings and related stocks such as Orthofix Medical, SurModics, and Pulmonx Corp Other Stockholder Equity description

My Equities

My Current Equities and Potential Positions

Zimmer Biomet Holdings
ZBH
ClassificationObamacare Repeal
LocationIndiana; U.S.A
ExchangeNew York Stock Exchange
USD 100.52
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out Zimmer Biomet Performance and Zimmer Biomet Correlation.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Zimmer Biomet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Zimmer Biomet technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Zimmer Biomet trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...